Remicade May Increase Cancer Risk, Johnson & Johnson Warns
Source: Reuters
Johnson & Johnson sent doctors a warning letter about the increased risk of lymphoma, a blood cancer, in patients taking its rheumatoid arthritis drug Remicade, Reuters reported last week.
The warning comes in the wake of Merck’s decision to pull its arthritis drug Vioxx from all worldwide markets after a study confirmed that it increases a patients’ risk of heart attack and stroke.
Patients taking Remicade suffered lymphoma at three times the rate of the general public, Centocor, the J&J unit that markets Remicade, wrote in the letter.
Remicade’s label will be revised to reflect the lymphoma risk.
Ft Myers Florida Golf Resorts, Vacations, & Real Estate
Golf Vacation Rental in Fort Myers, Naples, and Cape Coral Florida
Finishing Touch Massage – Massage Spa in Dallas We provide an exceptional massage experience to our clients in the North Dallas and surrounding areas (Plano, Richardson, Allen, Highland Park, Addison, etc). 214.360.4RMT
Tags: remicade
